MedTech Innovator

Leadoptik is a California-based company operating in stealth mode, focused on developing advanced miniature imaging technology for minimally invasive medical procedures. This innovative technology enhances surgeons' ability to view small objects with improved clarity compared to existing imaging systems, offering 3D navigation capabilities and high-resolution imaging. By facilitating the early detection of cancer in patients, Leadoptik aims to significantly improve surgical outcomes and patient care.

New View Surgical, Inc. is a Boston-based medical device company that specializes in the development and commercialization of the VisionPort technology, a novel surgical imaging and access system designed for minimally invasive surgery. Founded in 2009, the company has created a proprietary system that integrates four essential devices—a laparoscope, camera, light source, and access port—into a single, easy-to-use, and disposable unit. This innovation aims to provide surgeons with enhanced control over visualization and instrumentation during procedures, addressing various unmet needs within the surgical market. The leadership team comprises experienced professionals in medical device innovation and commercialization, dedicated to delivering impactful solutions that offer both clinical and economic benefits to operating rooms worldwide.

ClearCam Inc. is a medical technology company based in Austin, Texas, founded in 2018. The company specializes in manufacturing a laparoscopic lens cleaner device known as ClearCam Kelling, which is designed to enhance the visual field for surgeons during laparoscopic procedures. This innovative device allows for intra-operative lens cleaning without the need to remove the laparoscope from the body cavity, thereby streamlining surgical processes and improving safety. By eliminating the requirement for additional supplies, ClearCam's technology contributes to reduced procedure time, benefiting patients, surgeons, and surgical staff alike.

Avisi Technologies Inc. is focused on developing innovative solutions to combat glaucoma, a leading cause of irreversible blindness. The company has created VisiPlate, a next-generation aqueous shunt designed for mid to late-stage glaucoma treatment. This product is notable for its ultrathin design, being 20 times thinner than a human hair, which facilitates a less invasive insertion procedure that reduces operating time and simplifies follow-up care. VisiPlate is constructed from alumina, a material recognized for its use in hip replacements, thus ensuring biocompatibility. Founded in 2017 and headquartered in Philadelphia, Pennsylvania, Avisi Technologies aims to address the challenges associated with current glaucoma treatments, including patient non-compliance and post-operative complications, ultimately striving to prevent blindness in affected individuals.

Evergaze, Inc. is a company based in Richardson, Texas, that focuses on developing innovative visual aids for individuals with macular degeneration. Established in 2016, Evergaze has created a unique device that consists of prescription glasses equipped with a monocular electronic vision augmentation system on one lens. The founding team comprises experienced engineers who have leveraged their expertise from various technical sectors to design this product. The seeBoost® device was developed through extensive collaboration with patients, practitioners, and researchers in the field of low vision, embodying a commitment to addressing the needs of those affected by visual impairments.

Darmiyan, Inc. is a company that specializes in the development of diagnostic software aimed at the early detection and monitoring of Alzheimer's disease and other neurodegenerative disorders. Based in San Francisco and founded in 2014, the company offers BrainSee, a Software as a Service platform that utilizes non-invasive brain MRI scans to produce detailed brain maps. This innovative tool quantifies neurodegeneration in individual brain voxels and generates a summary score reflecting brain health and the risk of cognitive decline. BrainSee operates using proprietary technology, referred to as The Virtual Microscope, which provides insights into brain cell distortion before clinical symptoms manifest. The algorithm has undergone successful third-party validation in the US and Canada, demonstrating its accuracy in predicting mild cognitive impairment. By leveraging advanced medical imaging and artificial intelligence, Darmiyan aims to enhance early diagnosis and intervention for patients with neurodegenerative diseases.

CU-BX provides high-accuracy measurements of driver health parameters, fatigue, stress, and comfort. Our patented technology maintains high-level accuracy across all road and lighting conditions and is agnostic to clothing and other accessories such as masks, sunglasses, headwear, etc. CU-BX works closely with all key automotive players (OEMs, Tier-1 and Tier-2 manufacturers) on providing driver monitoring systems (DMS) as well as aftermarket solutions. See our 1-pager here: https://www.dropbox.com/s/a0bp4dmmcwlwoe0/CU-BX_Automotive_OnePager.pdf?dl=0

Augmedics is a provider of augmented reality (AR) surgical image guidance solutions. Augmedics seeks to improve healthcare by developing cutting-edge technologies that will revolutionize surgical treatment. The company’s first product, the xvision-spine (XVS) system, is an augmented-reality surgical navigation system designed to allow surgeons to see and navigate inside a patient’s body during complex procedures.

MobileODT Ltd specializes in developing optical diagnostic devices and software focused on early cancer detection, particularly cervical cancer. The company's flagship product, the EVA COLPO, is a portable, internet-connected colposcope that is FDA-cleared and designed for ease of use. MobileODT also offers EVA SANE, a secure platform for managing patient information, and EVA WELL, a digital visualization tool for gynecologic exams. Their offerings include a mobile application for remote image capture and patient tracking, along with a cloud-based portal for collaboration and reporting. In addition, the company provides tools for documenting violence and abuse and plans to expand its product line to cover other medical areas such as ENT and dermatology. Established in 2012 and headquartered in Tel Aviv, Israel, with an office in New York, MobileODT has gained recognition in various markets, particularly the United States, where it is becoming a standard for visual diagnostics in healthcare settings.

Bionic Vision Technologies Pty Ltd is an Australian company focused on developing visual prostheses aimed at restoring vision to individuals affected by blindness, particularly those with inherited retinal diseases. Founded in 2007 and based in Carlton, the company creates a suprachoroidal visual implant system that works by electrically stimulating the remaining retinal cells in patients with retinal degeneration. The innovative devices operate by capturing images through a camera mounted on an eyeglass frame, which are then converted into electrical signals. These signals stimulate the nerves using electrodes placed behind the retina, allowing visual information to be transmitted to the brain. Through this technology, Bionic Vision Technologies seeks to improve the quality of life for blind patients by enhancing their eyesight.

Diagnostic Photonics, Inc. specializes in advanced imaging technologies designed to aid physicians in the real-time assessment of tissue microstructure. Founded in 2008 and headquartered in Chicago, Illinois, the company has developed the Foresee Imaging System, which produces diffraction-corrected images to enhance tissue evaluation. The innovative imaging technology stems from research conducted at the Beckman Institute for Advanced Science and Technology at the University of Illinois, known for its interdisciplinary approach to scientific advancement.

LensGen, Inc. is an ophthalmic medical device company based in Irvine, California, that focuses on developing innovative solutions for presbyopia and cataracts. Founded in 2011, the company has created a biomimetic, curvature-changing intraocular lens designed to mimic the natural human lens. This lens, known as Juvene™, utilizes the eye's natural muscle contractions to adjust its shape and dioptric power on demand, allowing for clear and continuous vision at all distances. By restoring youthful vision, LensGen's technology eliminates the need for reading glasses, offering a significant advancement in the treatment of age-related vision issues.

LensGen, Inc. is an ophthalmic medical device company based in Irvine, California, that focuses on developing innovative solutions for presbyopia and cataracts. Founded in 2011, the company has created a biomimetic, curvature-changing intraocular lens designed to mimic the natural human lens. This lens, known as Juvene™, utilizes the eye's natural muscle contractions to adjust its shape and dioptric power on demand, allowing for clear and continuous vision at all distances. By restoring youthful vision, LensGen's technology eliminates the need for reading glasses, offering a significant advancement in the treatment of age-related vision issues.

Yolia Health, based in Mexico City, specializes in developing medical equipment aimed at preserving, restoring, and enhancing vision. The company's flagship product, the True Vision Treatment (TVT), is a non-invasive approach to correcting vision issues such as presbyopia. This innovative treatment allows patients to self-administer a combination of customized contact lenses and specially formulated eye drops in the comfort of their own homes. Remarkably, after just five days of treatment, patients can cease using both the TVT Contacts and Eye Drops, as well as their reading glasses, for up to 12 months before requiring re-treatment. Yolia Health's approach uniquely improves both near and distance vision without compromising either, setting it apart from other alternatives in the market. The company is currently seeking sophisticated investors and key industry partners to further its mission.